Opinion
Video
Author(s):
In this video, Dr. Hannah Choe provides an overview of the background of graft-versus-host disease (GVHD), discusses currently approved treatments and their limitations, and the significant unmet treatment needs in GVHD.
Liso-Cel Elicits Consistent Responses in R/R CLL/SLL, Irrespective of High-Risk Features
Revisit the OncLive On Air Episodes From February 2024
NCCN Adds Denileukin Diftitox to CTCL Clinical Practice Guidelines in Oncology
Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS
Novel Cell-Free DNA Assays Expand the Reach of MRD Detection in Lymphoma
Tisagenlecleucel Climbs into Earlier Lines of Therapy for Pediatric R/R B-ALL
Subcutaneous Rituximab Remains Underutilized in Non-Hodgkin Lymphoma
Dr Seymour on the Role of Mutational Profiling in CLL
Valemetostat Demonstrates Clinically Meaningful Efficacy in R/R PTCL